Currently, there are 2.13B common shares owned by the public and among those 2.09B shares have been available to trade.
The company’s stock has a 5-day price change of -1.54% and 7.62% over the past three months. PCG shares are trading 9.65% year to date (YTD), with the 12-month market performance up to 15.82% higher. It has a 12-month low price of $14.71 and touched a high of $20.65 over the same period. PCG has an average intraday trading volume of 13.41 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.40%, 6.83%, and 12.55% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of PG&E Corp. (NYSE: PCG) shares accounts for 93.36% of the company’s 2.13B shares outstanding.
It has a market capitalization of $42.26B and a beta (3y monthly) value of 1.02. The stock’s trailing 12-month PE ratio is 16.78, while the earnings-per-share (ttm) stands at $1.18. The company has a PEG of 1.75 and a Quick Ratio of 0.86 with the debt-to-equity ratio at 2.31. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.05% over the week and 1.70% over the month.
Earnings per share for the fiscal year are expected to increase by 10.54%, and 9.33% over the next financial year.
Looking at the support for the PCG, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on September 12, 2024, with the firm’s price target at $24. JP Morgan coverage for the PG&E Corp. (PCG) stock in a research note released on June 10, 2024 offered a Overweight rating with a price target of $22. Goldman was of a view on April 10, 2024 that the stock is Buy, while Evercore ISI gave the stock In-line rating on October 23, 2023, issuing a price target of $16. Barclays on their part issued Overweight rating on August 23, 2023.
